🪰

Determining Whether Sleep Deprivation Contributes to Locomotor Deficits in Aβ-42 Transgenic Drosophila melanogaster

Zoe Singer

SOMERS Science Fair  ·  Medicine & Health  ·  F-LS-MED-553

📊 Key Statistics

😴 30% of adults affected by sleep deprivation
🧠 15% of Alzheimer's cases linked to sleep disruption
⬆️ Aβ-42 levels increase when sleep is impaired

🔬 Introduction

How Sleep Deprivation Drives Alzheimer's Risk

😴 Lack of Sleep
→
🧫 Build-up of Aβ-42 Toxins
→
🧠 Alzheimer's Disease

What is Alzheimer's Disease?

A brain disorder that destroys memory and the ability to complete daily tasks. Amyloid-beta plaques disrupt neuron communication and ultimately cause cell death.

Why Drosophila melanogaster?

  • Well-established model for studying neurodegeneration
  • Provides insights into mechanisms of Alzheimer's disease
  • Allows testing of risk factors on disease phenotypes
  • Short lifespan enables rapid longitudinal observation
⚠️ Knowledge Gap: It is unclear whether sleep deprivation in Aβ-42 transgenic Drosophila melanogaster contributes to an earlier onset of Alzheimer-like symptoms.

📚 Review of Literature

👥

Sügün et al. (2025)

  • ~15% of AD cases due to sleep disruption
  • Aβ-42 levels increase when sleep is impaired
  • Sleep is a target for early detection & prevention
😴

Baril et al. (2024)

  • Longer sleep duration associated with AD development
  • Daytime napping linked to worse cognition
  • Both processes may trigger neuroinflammation
🪰

Emerson et al. (2020)

  • Used Tau mutant Drosophila as model
  • Did not measure effects over time
  • Sleep deprivation does affect locomotion in Tau mutant

🎯 Purpose

To determine if sleep deprivation in Aβ-42 transgenic Drosophila melanogaster can increase the risk of developing Alzheimer-like symptoms in a shorter period of time than non-sleep-deprived mutants.

Sleep Deprivation Aβ-42 Transgenic Early Locomotor Decline?

💡 Hypothesis

The sleep-deprived Aβ-42 transgenic Drosophila melanogaster mutants will develop locomotor deficits in a shorter period of time than the non-sleep-deprived mutants.

Expected Locomotor Performance Over Time
High Low Days of Life → 1 5 10 15 20
Non-Sleep Deprived Sleep Deprived

🧪 Intended Methodology

Model Organism

🪰

Aβ-42 Transgenic Drosophila melanogaster

UAS "Arctic" Aβ-42 × Neuronal GAL4

Controlled Conditions

☀️🌙
12h / 12h
Light/Dark
🌡️
22°C
Temperature
🌽
Cornmeal
Diet

Variables

TypeVariable
IndependentSleep deprivation in Drosophila
DependentLocomotor ability of Drosophila
ControlledLight cycle, temperature, diet

📅 Assay Timeline — Negative Geotaxis

1
Day 1
Baseline
5
Day 5
Early
10
Day 10
Mid
15
Day 15
Late
20
Day 20
Final

Demonstrating Sleep Deprivation

🔧 Assemble Power Tower
→
😴 Continuously Deprive Flies of Sleep
→
📡 Use DAM System
→
📈 Monitor Sleep in Both Groups

Tracking Locomotor Decline

🪰 Separate Files into Two Groups
→
⚡ Power Tower: Continuously Deprive Sleep Group
→
📐 Negative Geotaxis Assay at Days 1, 5, 10, 15, 20

📈 Related Results

📊 Figure 1 — AD Risk & Sleep (He et al., 2022)
Daytime Sleepiness Sleep Duration Association Strength High AD Genetic Risk Clinical AD Diagnosis

High AD polygenic risk is not associated with daytime sleepiness but is associated with reduced nighttime sleep duration. Clinical AD diagnosis amplifies both associations.

🧠 Figure 2 — Aβ Accumulation & Sleep Timing (Michelli et al., 2021)
☀️ Day Deprived
Low Aβ
🌙 Night Deprived
HIGH Aβ ⚠️

Aβ accumulation is significantly higher in flies deprived of sleep at night vs. during the day, confirming a bidirectional link between sleep timing and amyloid-beta deposition.

🔍 Analysis & Discussion

Take Aways From Figure 1

Key Finding: High genetic AD risk was NOT associated with daytime sleepiness — but was associated with a significant reduction in nighttime sleep.

Expected Results

When nighttime sleep duration is disrupted, there will be a locomotor decline in flies — likely due to increased amyloid-beta deposition in the brain.

Nighttime Sleep Quality Poor Adequate ⚠️ Sleep-deprived group falls here

Take Aways From Figure 2

Key Finding: Bidirectional relationship between sleep and AD risk. Loss of sleep promotes Aβ accumulation → development of Alzheimer's.

Expected Results

Sleep deprivation will cause Alzheimer-like symptoms to occur in sleep-deprived flies earlier than in non-sleep-deprived flies.

Projected Aβ Accumulation Over 20 Days
Days → Aβ Level 1 5 10 15 20
Non-Sleep Deprived Sleep Deprived

✅ Conclusion

🧬

This study aims to determine whether sleep deprivation in Aβ-42 transgenic Drosophila melanogaster will cause the flies to experience decreased locomotor ability.

It is expected that the sleep-deprived transgenic flies will show decreased locomotor abilities earlier than the non-sleep-deprived flies — providing evidence that sleep deprivation accelerates Alzheimer-like disease progression.

Predicted Causal Chain

🌙 Sleep Deprivation
→
⬆️ Aβ-42 Accumulation
→
🧠 Neurodegeneration
→
🪰 Early Locomotor Deficits

🔭 Application & Future Focus

🌍 Application

  • Raise awareness about the adverse consequences of sleep deprivation on brain health
  • Support evidence from human studies that lack of sleep accelerates AD risk
  • Inform prevention strategies targeting sleep as a modifiable risk factor

🔬 Future Focus

🔬 Immunohistochemistry

Track amyloid-beta plaques directly in fly brains — measure deposition over time to confirm accumulation rates between groups.

💊 Rescue Treatment

Test a sleep-deprivation remedy to see if it can prevent or delay Alzheimer-like symptoms in the same transgenic flies.